AQUESTIVE THERAPEUTICS INC(NASDAQ:AQST) stock News

AQST Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer

3 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer

10 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film

10 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film

3 months ago - By: Benzinga

Uncovering Potential: Aquestive Therapeutics's Earnings Preview

18 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

18 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

23 days ago - By: Yahoo Finance - Mentions: APLS

H.C. Wainwright Reaffirms Buy on Aquestive Therapeutics, Inc. (AQST) After FDA Approval

a month ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit

a month ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit

a month ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions

2 months ago - By: Yahoo Finance - Mentions: BNTX AES TSLA MRNA ...

BioNTech Strengthens UK Ties with Investment of Up to $1.33 Billion

2 months ago - By: Yahoo Finance - Mentions: ATYR ATAI IBRX

aTyr Pharma, Inc. (ATYR): Analysts See 485% Upside Potential

2 months ago - By: Yahoo Finance - Mentions: LXRX PAHC MMSI ITGR ...

Lexicon Pharmaceuticals, Inc. (LXRX): Analysts See 285% Upside Potential

2 months ago - By: Yahoo Finance

Aquestive Therapeutics, Inc. (AQST): Analysts See 245% Upside Potential

2 months ago - By: Zacks Investment Research

Aquestive Therapeutics (AQST) Reports Q1 Earnings: What Key Metrics Have to Say

2 months ago - By: Zacks Investment Research - Mentions: CASI

Aquestive Therapeutics (AQST) Reports Q1 Loss, Lags Revenue Estimates

2 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

2 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

2 months ago - By: Yahoo Finance - Mentions: BROS CART ATKR TFC ...

Is Dutch Bros Inc. (BROS) Among the Best Restaurant Stocks to Buy According to Hedge Funds?

2 months ago - By: Benzinga - Mentions: LAND EDIT LINC VTLE ...

Earnings Scheduled For May 12, 2025

3 months ago - By: Zacks Investment Research - Mentions: COLL

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates

3 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Participate in Citizens Life Sciences Conference

3 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET

3 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET

4 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium

4 months ago - By: Aquestive Therapeutics, Inc.